The energy-saving review for Hubei Hongyuan Pharmaceutical’s 6,000-ton/year expansion project for high-purity lithium hexafluorophosphate crystals has been approved

Thread Content

On November 24, the Development and Reform Bureau of Luotian County approved the energy efficiency assessment for Hubei Hongyuan Pharmaceutical Technology Co., Ltd.’s project to expand its production capacity for high-purity lithium hexafluorophosphate at a rate of 6,000 tons per year. The details of the project are as follows: It is understood that the investment in this project amounts to 356.08 million yuan, and it is located at No. 8 Hongyuan Road, Luotian County Economic Development Zone. The main new constructions include a 6,000-ton/year lithium hexafluorophosphate production facility, a nitrogen generation station, initial rainwater tanks, and a barrel washing room ； Renovate the 2,000-ton finished product workshop; the rest will make use of the company’s existing facilities. Regarding Hubei Hongyuan Pharmaceutical Technology Co., Ltd.: Established in 2002, the company has a registered capital of 400 million yuan. It has built a relatively complete pharmaceutical industry chain, covering the entire product development process for nitroimidazole-based antibacterial drugs and antiviral drugs – from starting materials and key intermediates to active pharmaceutical ingredients and finally to finished products. As one of the major suppliers of nitroimidazole-based antibacterial active pharmaceutical ingredients and intermediates, antiviral active pharmaceutical ingredients and intermediates, as well as penicillin-based antibacterial drug intermediates worldwide, the company holds a leading market share in its core products.